Study: Drug lets obese mice live longer, holds hope for humans

08/19/2011 | New York Times (tiered subscription model), The

A specially designed drug called SRT-1720 has been shown to extend life an average of 44% for obese mice by decreasing fat in the liver and increasing sensitivity to insulin, according to research from the National Institute on Aging. Similar drugs are being tested in human clinical trials, with an eye on creating drugs to help people of all sizes live longer.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC